<--- Back to Details
First PageDocument Content
Asthma / Exercise-induced asthma / Bronchodilator / Peak expiratory flow / Salmeterol / Fluticasone/salmeterol / Montelukast / Budesonide/formoterol / Pathophysiology of asthma / Pulmonology / Medicine / Respiratory therapy
Date: 2013-10-09 03:50:53
Asthma
Exercise-induced asthma
Bronchodilator
Peak expiratory flow
Salmeterol
Fluticasone/salmeterol
Montelukast
Budesonide/formoterol
Pathophysiology of asthma
Pulmonology
Medicine
Respiratory therapy

Asthma Foundation WA 36 Ord Street West Perth, WA 6005 PO Box 864 West Perth WA 6872 Telephone

Add to Reading List

Source URL: www.asthmawa.org.au

Download Document from Source Website

File Size: 279,23 KB

Share Document on Facebook

Similar Documents

Microsoft Word - Prosonix full abstract for DDL22_2_.doc

Microsoft Word - Prosonix full abstract for DDL22_2_.doc

DocID: 1rcKt - View Document

COPD Care Map for Primary Care  Patient Name: ______________________________________ DOB: ________________ Year of diagnosis:___________ Co-morbid conditions:______________________________________________________________

COPD Care Map for Primary Care Patient Name: ______________________________________ DOB: ________________ Year of diagnosis:___________ Co-morbid conditions:______________________________________________________________

DocID: 1qO6l - View Document

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth

DocID: 1oNoo - View Document

European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using

European Respiratory Disease Volume 8 • Issue 1 • Spring 2012 • Extract Improved Localised Lung Delivery Using

DocID: 1ooQZ - View Document

PIPELINE WATCH  Seretide SPCs reach the end of the road eptember brings the expiry of supplementary protection certificates (SPCs) for GlaxoSmithKline’s Seretide (fluticasone/salmeterol) blockbuster in several European

PIPELINE WATCH Seretide SPCs reach the end of the road eptember brings the expiry of supplementary protection certificates (SPCs) for GlaxoSmithKline’s Seretide (fluticasone/salmeterol) blockbuster in several European

DocID: 1mZXk - View Document